| 0.3504 -0.045 (-11.27%) | 10-16 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 0.56  |
1-year : | 0.66 |
| Resists | First : | 0.48 |
Second : | 0.56 |
| Pivot price | 0.44 |
|||
| Supports | First : | 0.34 |
Second : | 0.29 |
| MAs | MA(5) : | 0.39 |
MA(20) : | 0.46 |
| MA(100) : | 0.54 |
MA(250) : | 1.11 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 4.9 |
D(3) : | 5.2 |
| RSI | RSI(14): 25.3 |
|||
| 52-week | High : | 2.79 | Low : | 0.34 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ AIFC ] has closed below the lower bollinger band by 2.5%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ AIFC ] is to continue within current trading range. Bollinger Bands are 17% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.4 - 0.4 | 0.4 - 0.4 |
| Low: | 0.34 - 0.35 | 0.35 - 0.35 |
| Close: | 0.35 - 0.36 | 0.36 - 0.37 |
AI Financial Corporation, a global entity operating through its various subsidiaries, specializes in distributed ledger technology solutions. The company's activities are strategically divided into two primary segments: Fintech and Biotechnology. Its Fintech division manages the entire ecosystem of digital assets, covering everything from their initial creation (tokenization) to their trading, clearing, settlement, payment processing, and secure safekeeping. Within this sector, AI Financial offers significant products such as ALT 5 Prime, a sophisticated electronic over-the-counter (OTC) trading platform designed for the acquisition and divestiture of digital assets. Another key offering is ALT 5 Pay, a cryptocurrency payment gateway that empowers merchants to either accept and disburse payments in digital currencies directly or integrate this capability into their existing software applications. The biotechnology arm is dedicated to identifying, procuring, licensing, advancing, collaborating on, and commercializing innovative, non-opioid, and non-addictive therapeutic solutions for addressing pain and addiction. Noteworthy projects include JAN 101, an orally administered, sustained-release sodium nitrite compound that has successfully concluded Phase 2a clinical trials for the treatment of peripheral arterial disease and pain. Additionally, the company is developing JAN123, a low-dose naltrexone formulation specifically tailored for managing chronic regional pain syndrome. Established in 1976, the company is based in Las Vegas, Nevada. It officially adopted its current name, AI Financial Corporation, in April 2026, having previously been known as ALT5 Sigma Corporation.
Wed, 14 Oct 2026
AI Financial Rebrands Alyea Therapeutics as Drew Therapeutics in Honor of Andrew Witkoff - citybiz
Wed, 14 Oct 2026
AI Financial rebrands biotech unit as Drew Therapeutics - Investing.com
Wed, 14 Oct 2026
AI Financial Corporation (AIFC) Plans Biotech Spin-Off as Drew Therapeutics - TradingView
Mon, 17 Aug 2026
AI Financial Corp Q2 2026: Revenue $2.41M, EPS $(1.68) — 10-Q Summary - TradingView
Thu, 23 Jul 2026
AI Financial CEO Sets the Record Straight on Misleading Media Reporting and Previews Strategic Roadmap - ACCESS Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Infrastructure
|
|
| Shares Out | 140 (M) |
| Shares Float | 125 (M) |
| Held by Insiders | 2 (%) |
| Held by Institutions | 28.4 (%) |
| Shares Short | 11,660 (K) |
| Shares Short P.Month | 13,130 (K) |
| EPS | -10.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.73 |
| Profit Margin | 0 % |
| Operating Margin | -29.4 % |
| Return on Assets (ttm) | -3.5 % |
| Return on Equity (ttm) | -235.2 % |
| Qtrly Rev. Growth | -62.3 % |
| Gross Profit (p.s.) | 0.07 |
| Sales Per Share | 0.14 |
| EBITDA (p.s.) | -0.14 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -19 (M) |
| Levered Free Cash Flow | -5 (M) |
| PE Ratio | -0.04 |
| PEG Ratio | 0.9 |
| Price to Book value | 0.07 |
| Price to Sales | 2.49 |
| Price to Cash Flow | -2.66 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|